Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication errors analysis is an opportunity to improve practice

I E Mohseni1, D H Wong

  • 1Practitioner Reporting Programs, United States Pharmacopeia, Rockville, Maryland 20852, USA.

American Journal of Surgery
|January 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of eptifibatide and abciximab with decision analysis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2001
Same author

Biochemical studies of Zmpste24-deficient mice.

The Journal of biological chemistry·2001
Same author

Is the pain of intravenous catheter insertion associated with hemodynamic changes?

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2000
Same author

Studies with recombinant Saccharomyces cerevisiae CaaX prenyl protease Rce1p.

Biochemistry·2000
Same author

Doppler stroke volume measurement: is it coming toward an intensive care unit near you?

Critical care medicine·1999
Same author

Liquid ventilation: more than "PEEP in a bottle"?

Critical care medicine·1999

The USP Medication Errors Reporting Program analyzed 2,213 reports, highlighting medication errors with neuromuscular blocking agents (NMB). Recommendations are provided to prevent these critical drug errors.

Area of Science:

  • Pharmacovigilance
  • Drug Safety
  • Healthcare Quality Improvement

Background:

  • The United States Pharmacopeia (USP) Medication Errors Reporting (MER) Program collected data from October 1991 to November 1996.
  • Medication errors are prevalent across all healthcare settings and disciplines, involving diverse drug classes.

Observation:

  • Neuromuscular blocking agents (NMB) were involved in 38 of the 2,213 reported medication errors.
  • Inappropriate use of NMB agents poses a significant risk of increased morbidity and mortality.
  • Reported causes of errors include similar-looking product packaging and labeling.

Findings:

  • Analysis of USP MER Program data reveals common causes and contributing factors to medication errors.
  • Practitioner-submitted suggestions offer insights into preventing recurrent medication errors.

Related Experiment Videos

  • The USP Advisory Panel on Medication Errors developed specific recommendations to mitigate NMB-related errors.

    • Implications:

    • The findings underscore the need for robust medication error reporting systems like the USP MER Program.
    • Implementing targeted recommendations can enhance patient safety, particularly concerning high-risk drug classes like NMB agents.
    • This educational guide serves to inform healthcare professionals about preventing medication errors across all drug categories.